Video Experimental Relacionado
Updated: Aug 15, 2026
14:58
Methods for the Modulation and Analysis of NF-κB-dependent Adult Neurogenesis
Published on: February 14, 2014
La mutación Nod2 en la enfermedad de Crohn potencia la actividad de NF-kappaB y el procesamiento de IL-1beta
Shin Maeda1, Li-Chung Hsu, Hongjun Liu
1Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0723, USA.
Science (New York, N.Y.)
|February 5, 2005
Resumen
Las variantes NOD2 relacionadas con la enfermedad de Crohn mejoran la detección bacteriana, lo que lleva a un aumento de la inflamación. Este estudio revela que NOD2 regula positivamente las respuestas inmunes, afectando la secreción de interleucina-1beta y la susceptibilidad a la inflamación intestinal.
Área de la Ciencia:
- Inmunología Inmunología.
- Gastroenterología y Gastroenterología.
- Biología Molecular Biología Molecular
Sus antecedentes:
- Las variantes NOD2 están asociadas con una mayor susceptibilidad a la enfermedad de Crohn (EC).
- Estas variantes están paradójicamente relacionadas con la actividad elevada del factor nuclear kappaB (NF-kappaB) en pacientes con CD, a pesar de los defectos teóricos.
- El papel preciso de NOD2 en la inmunidad innata y la inflamación intestinal sigue sin estar claro.
Objetivo del estudio:
- Para investigar el papel fisiopatológico de las variantes de NOD2 en respuesta a estímulos bacterianos.
- Para dilucidar la función de NOD2 en la regulación de la activación de NF-kappaB y la secreción de citoquinas in vivo.
- Para determinar el impacto de las variantes de NOD2 en la susceptibilidad a la inflamación intestinal inducida por bacterias.
Principales métodos:
- Generación de un modelo de ratón con una variante específica de NOD2 introducida en el locus Nod2 endógeno.
- Estimulación de ratones mutantes con muramil dipeptido (MDP), un ligando derivado de bacterias para el NOD2.
- Evaluación de la activación de NF-kappaB, el procesamiento y la secreción de interleucina-1beta (IL-1beta) y la inflamación intestinal.
Principales resultados:
- Los ratones mutantes exhibieron una mayor activación de NF-kappaB tras la estimulación del MDP.
- Se observó un mejor procesamiento y secreción de la citoquina proinflamatoria IL-1beta en ratones mutantes.
- La expresión de la variante NOD2 se correlacionó con una mayor susceptibilidad a la inflamación intestinal inducida por bacterias.
Conclusiones:
- NOD2 actúa como un regulador positivo de la activación de NF-kappaB y la secreción de IL-1beta.
- Las variantes NOD2 disfuncionales contribuyen a la inflamación intestinal al mejorar estas respuestas inmunes.
- Estos hallazgos ofrecen nuevos conocimientos sobre la patogénesis de la enfermedad de Crohn.
Videos de Conceptos Relacionados
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...